Business Context and Reporting Period
This Form 6-K filing by DHT Holdings, Inc. covers the month of December 2011. The registrant is a foreign private issuer with principal executive offices in St. Helier, Jersey, Channel Islands.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
On December 20, 2011, the Company received notice from the New York Stock Exchange (NYSE) that it was no longer in compliance with continued listing standards. This non-compliance was triggered because the average closing price of the Company's common stock fell below $1.00 per share over a consecutive 30 trading-day period.
Outlook, Risks, and Management Commentary
- Cure Period: Under NYSE rules, the Company has a six-month cure period following the notice to restore its share price and average share price to above $1.00.
- Management Intent: The Company has formally notified the NYSE of its intention to cure this non-compliance.
- Risk: Failure to meet the listing standards within the cure period could result in delisting.
Investor Verification Checklist
- Verify the current trading price and 30-day average of DHT Holdings, Inc. common stock.
- Monitor subsequent filings for updates on the Company's progress toward meeting the $1.00 minimum bid price requirement.
- Review the Company's capital structure and potential actions (e.g., reverse stock split) that may be taken to address the listing deficiency.